U.S. Markets open in 2 hrs 53 mins
  • S&P Futures

    4,600.25
    -54.50 (-1.17%)
     
  • Dow Futures

    35,523.00
    -273.00 (-0.76%)
     
  • Nasdaq Futures

    15,312.25
    -283.50 (-1.82%)
     
  • Russell 2000 Futures

    2,132.70
    -25.00 (-1.16%)
     
  • Crude Oil

    85.28
    +1.46 (+1.74%)
     
  • Gold

    1,810.40
    -6.10 (-0.34%)
     
  • Silver

    22.88
    -0.04 (-0.19%)
     
  • EUR/USD

    1.1391
    -0.0019 (-0.1709%)
     
  • 10-Yr Bond

    1.7720
    0.0000 (0.00%)
     
  • Vix

    21.72
    +1.41 (+6.94%)
     
  • GBP/USD

    1.3620
    -0.0027 (-0.1988%)
     
  • USD/JPY

    114.6890
    +0.1090 (+0.0951%)
     
  • BTC-USD

    41,807.95
    -933.32 (-2.18%)
     
  • CMC Crypto 200

    999.97
    -25.76 (-2.51%)
     
  • FTSE 100

    7,556.70
    -54.53 (-0.72%)
     
  • Nikkei 225

    28,257.25
    -76.27 (-0.27%)
     

Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, October 07, 2021--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the financial markets close on Wednesday, November 3, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2021 financial and operating results.

Conference Call/Webcast Details:

Date: November 3, 2021
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 4679227
Webcast Link: https://edge.media-server.com/mmc/p/tjyiohyv

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211007005756/en/

Contacts

Media Contact:
Steve Sabicer
714-907-6264
ssabicer@thesabicergroup.com

Investor Contact:
Susan Morrison
858-366-6900
smorrison@tandemdiabetes.com